Rights and permissions
About this article
Cite this article
Lenalidomide leads the way in 3 European countries. Pharmacoecon. Outcomes News 656, 6 (2012). https://doi.org/10.2165/00151234-201206560-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206560-00007